Just like any chronic health condition, polycythemia vera (PV) can have a negative impact on your everyday life. Research has ...

Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...

Every four minutes, someone in the U.S. is diagnosed with blood cancer, and thousands of patients with blood cancers like ...

In a strong validation of the company’s clinical trial, Imugene Ltd’s Phase 1b trial for its azer-cel off-the-shelf, allogeneic, CD19 CAR T therapy in relapsed/refractory diffuse large B-cell lymphoma ...

It's the number one cancer in Australian children[i], ripping away the childhoods of those affected, and what's more, it's on the rise.Its name is ...

Among adults with relapsed or refractory indolent B-cell non-Hodgkin lymphoma, the phase 2 TRANSCEND FL trial met its primary ...

A few students involved in the Leukemia and Lymphoma Society sit down with FOX43 to talk about the organization and future ...

The BC Cancer Foundation is looking to raise $6.8 million to expand its provincial immunotherapy research program, a ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Pfizer’s Takeda-partnered blood cancer drug Adcetris (brentuximab vedotin) has been approved by the US Food and Drug ...